Phase 1 Overweight or Obesity Clinical Trials
12 recruitingPhase 1
What is a Phase 1 trial?
Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.
Showing 1–12 of 12 trials
Recruiting
Phase 1
A Study of LY4064912 in Healthy Participants and With Overweight or Obesity
HealthyOverweight or Obesity
Eli Lilly and Company144 enrolled3 locationsNCT07152002
Recruiting
Phase 1
A Study of Multiple Doses of Orally Administered RO7795081 in Otherwise Healthy Chinese Adult Participants With Obesity or Overweight
Healthy VolunteersOverweight or Obesity
Hoffmann-La Roche30 enrolled2 locationsNCT07499050
Recruiting
Phase 1
A Study of IBI3032 in Chinese Healthy Participants and Participants With Overweight or Obesity
Part A: Healthy Part B: Overweight or Obesity
Innovent Biologics Technology Limited (Shanghai R&D Center)104 enrolled1 locationNCT07160400
Recruiting
Phase 1
The Safety, Tolerability, and Pharmacokinetics of of SYH9017 in Chinese Participants With Overweight and Obesity
Overweight or Obesity
CSPC Baike (Shandong) Biopharmaceutical Co., Ltd.66 enrolled1 locationNCT06830343
Recruiting
Phase 1Phase 2
The Efficacy and Safety of Metformin Intervention in Elderly Overweight or Obesity With Mild Cognitive Impairment
ElderlyMild Cognitive ImpairmentOverweight or Obesity
Fudan University54 enrolled1 locationNCT07395960
Recruiting
Phase 1
A Study of BGM1812 Injection in Healthy and Non-diabetic Overweight or Obese Chinese Participants
Overweight or Obesity
BrightGene Bio-Medical Technology Co., Ltd.60 enrolled1 locationNCT07294235
Recruiting
Phase 1
A Study to Evaluate MWN109 Tablets in Healthy Adult Participants
Overweight or Obesity
Shanghai Minwei Biotechnology Co., Ltd60 enrolled2 locationsNCT06938269
Recruiting
Phase 1
Relative Bioavailability of First vs Second-Generation Formulations of HRS9531 Tablets in Obese or Overweight Subjects
Overweight or Obesity
Fujian Shengdi Pharmaceutical Co., Ltd.168 enrolled1 locationNCT07150962
Recruiting
Phase 1
Evaluate the Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of BGM1812 Injection Following Single and Multiple Subcutaneous Administration in Normal to Overweight or Obese But Otherwise Healthy Men and Women
HealhtyOverweight or Obesity
BrightGene Bio-Medical Technology Co., Ltd.60 enrolled1 locationNCT07224399
Recruiting
Phase 1
A Study to Evaluate Features of KN069 in Participants With Obesity or Overweight
Overweight or Obesity
Suzhou Alphamab Co., Ltd.36 enrolled1 locationNCT06547775
Recruiting
Phase 1
A Study of HS-20094 in Overweight or Obese Participants
Overweight or Obesity
Jiangsu Hansoh Pharmaceutical Co., Ltd.144 enrolled1 locationNCT07057674
Recruiting
Phase 1
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of HRS-4729 Injection in Healthy Subjects
Overweight or Obesity
Fujian Shengdi Pharmaceutical Co., Ltd.103 enrolled1 locationNCT06762600